Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): Updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin's lymphoma (NHL) Meeting Abstract
| Authors: | Younes, A.; Flinn, I.; Berdeja, J.; Friedberg, J. W.; Casulo, C.; Thieblemont, C.; Morschhauser, F.; Westin, J. R.; Seetharam, S.; Hellemans, P.; Smit, H.; de Vries, R.; Dauphinee, E.; Badamo-Dotzis, J.; Fourneau, N.; Oki, Y. |
| Abstract Title: | Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): Updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin's lymphoma (NHL) |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385002023 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.852.852 |
| Notes: | Meeting Abstract: 852 -- Source: Wos |
